Stay updated on Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page
- Check6 days agoChange DetectedAdded related topics: Rheumatoid arthritis and MedlinePlus Genetics, expanding the page's links to disease resources. This update enhances access to genetics and disease-specific information related to the study.SummaryDifference0.0%

- Check7 days agoChange DetectedUpdates to the study’s location details include added entries for specific administrative regions and cities (e.g., regional designations for Araucanía/Temuco, Moravian-Silesian/A Hlučín, Olomouc Region/Olomouc, Ādaži, and Bucharest), along with a revision version change. These changes reflect formatting/label adjustments rather than any alteration to the trial information or outcomes.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAdded related topics: Rheumatoid arthritis and MedlinePlus Genetics to the page.SummaryDifference0.0%

- Check43 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check50 days agoChange DetectedRemoved related topics in the page's sidebar: 'Rheumatoid arthritis' and 'MedlinePlus Genetics'. This is a metadata/navigation change that does not modify the study details or results.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded related topics: Rheumatoid arthritis and MedlinePlus Genetics. Updated the site revision from v3.4.2 to v3.4.3; core study content remains unchanged.SummaryDifference0.1%

Stay in the know with updates to Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.